Employees: 11 (2023.0)Legal category: SCA (commandite par actions)Size: PMECreation date: 2009-04-30 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ROQUEBRUNE-CAP-MARTIN (06190), Alpes-Maritimes
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE DU CAP MARTIN : revenue, balance sheet and financial ratios
SELAS PHARMACIE DU CAP MARTIN is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ROQUEBRUNE-CAP-MARTIN (06190),
this company of category PME
shows in 2024 a net income positive of 248 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE DU CAP MARTIN (SIREN 512300492)
Indicator
2024
2023
2022
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
247 649 €
207 445 €
243 242 €
161 069 €
197 298 €
189 885 €
145 672 €
74 914 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SELAS PHARMACIE DU CAP MARTIN generates positive net income of 248 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 75 k€ -> 248 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
247 649 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 65%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
64.816%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
52.092%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELAS PHARMACIE DU CAP MARTIN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
Debt ratio
325.801
242.911
185.417
148.655
167.874
100.689
82.068
64.816
Financial autonomy
19.721
23.444
27.846
31.886
31.168
39.846
44.768
52.092
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
64.822024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of SELAS PHARMACIE DU CAP MA... (64.82) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
52.09%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+12 pts over 3 years
In 2024, the financial autonomy of SELAS PHARMACIE DU CAP MA... (52.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 221.84. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
221.836
Liquidity indicators evolution SELAS PHARMACIE DU CAP MARTIN
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
Liquidity ratio
124.543
117.893
118.101
104.676
189.341
171.667
180.995
221.836
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
221.842024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+25 pts over 3 years
In 2024, the liquidity ratio of SELAS PHARMACIE DU CAP MA... (221.84) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of SELAS PHARMACIE DU CAP MARTIN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELAS PHARMACIE DU CAP MARTIN is estimated at
3 457 363 €
(range 2 407 653€ - 5 172 413€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2407k€3457k€5172k€
3 457 363 €Range: 2 407 653€ - 5 172 413€
NAF 5 année 2024
Valuation method used
Net Income Multiple
247 649 €
×
14.0x
=3 457 363 €
Range: 2 407 653€ - 5 172 413€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE DU CAP MARTIN with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE DU CAP MARTIN
What is the revenue of SELAS PHARMACIE DU CAP MARTIN ?
The revenue of SELAS PHARMACIE DU CAP MARTIN is not publicly disclosed (confidential accounts filed with INPI).
Is SELAS PHARMACIE DU CAP MARTIN profitable?
Yes, SELAS PHARMACIE DU CAP MARTIN generated a net profit of 248 k€ in 2024.
Where is the headquarters of SELAS PHARMACIE DU CAP MARTIN ?
The headquarters of SELAS PHARMACIE DU CAP MARTIN is located in ROQUEBRUNE-CAP-MARTIN (06190), in the department Alpes-Maritimes.
Where to find the tax return of SELAS PHARMACIE DU CAP MARTIN ?
The tax return of SELAS PHARMACIE DU CAP MARTIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE DU CAP MARTIN operate?
SELAS PHARMACIE DU CAP MARTIN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart